Statements not achieving consensus when agree and strongly agree is combined as one answer
| Statement | Responses: agree or strongly agree |
| When a patient presents with new respiratory symptoms while using a medication known to cause DI-ILD, initial investigations and management should focus around more common causes of symptoms | 16 (49%) |
| Pulsed i.v. cyclophosphamide should be considered in those patients not responding to i.v. methylprednisolone or oral prednisolone | 14 (42%) |
| In patients responding to therapy, follow-up should occur within 6 weeks of initial therapy | 24 (73%) |
| If a drug has been proven, or is highly suspected, to have caused DI-ILD, if no alternative agent is available and treatment is absolutely required, the offending drug should be cautiously reintroduced ideally at reduced dosage and with frequent monitoring (1–2 weekly) | 19 (58%) |
DI-ILD: drug-induced interstitial lung disease.